homeeconomy NewsGST Council extends concessions to specified COVID 19 drugs till December 31

GST Council extends concessions to specified COVID-19 drugs till December 31

The Goods and Services Tax (GST) Council has extended the concessions to specified drugs used in COVID-19 treatment till December 31, sources said.

By Timsy Jaipuria  Sept 17, 2021 1:28:04 PM IST (Updated)

CNBCTV 18
The Goods and Services Tax (GST) Council has extended the concessions to specified drugs used in COVID-19 treatment till December 31, sources told CNBC-TV18 on Friday.
The development comes as the 45th GST Council meeting, the first physical meet since the outbreak of the COVID-19 pandemic, chaired by Union Finance Minister Nirmala Sitharaman is underway.
According to sources, the council has also approved adding more medicines under concessional rates and has extended the relief by reducing GST rates from 12 percent to 5 percent on several drugs till December 31. These include Itolizumab, Posaconazole, Infliximab, Bamlanivimab & Etesevimab, Casirivimab & Imdevimab, 2-Deoxy-D-Glucose and Favipiravir.